EMA has 67 days to decide whether to back recommendation of its expert committee
Drug firm says says delisting would enhance liquidity of trading
Rare disease specialist says performance was ‘strong’ in ‘extremely busy’ period
Company upgrades forecasts as it completes Chiasma takeover
US Food and Drug Administration’s priority review can expedite review process to six months
Drug group expands its portfolio of medicines while reporting first-quarter numbers
Rolling submission began last summer
Results are a record for Dublin-based company, which has recently listed on Nasdaq
Swixx BioPharma will sell cholesterol drug across central and eastern Europe
Irish specialist in rare diseases says successful drug could tap $1bn market
Sectors include health and safety, pharma, crop protection and refrigeration
Chief executive Joe Wiley also received more than 6m share options in company
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices